Newcomer Lee Nisley bought MYGN

June 6, 2024 · Form 4 insider transaction

Newcomer Lee Nisley bought 15,695 shares of Myriad Genetics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
15,695
Price
$0.00
Total value
N/A
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJune 6, 2024
Filing dateJune 7, 2024
Shares owned after82,345
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant.

View the original Form 4 on SEC EDGAR